CONMED gains after Needham upgrades to 'buy' on strong revenue growth

Conmed

06/10/2021 13:47

** Shares of medical tech co  CNMD.N  up 1% at $131.87
premarket, after Needham upgrades to "buy" from "hold"
    ** Brokerage says CNMD's AirSeal and Buffalo Filter products
will drive revenue and margin growth over the next few years
    ** Expects CNMD to reach double-digit revenue growth in 2022
or 2023
    ** Says M&A could serve as a catalyst for CNMD shares
    ** Avg. stock rating is "buy"; median PT is $157.5 -
Refinitiv data
    

 (Reporting by Siddarth S)
 ((Siddarth.s@thomsonreuters.com;))